NCT03847051

Brief Summary

This study aims to assess the diagnostic feasibility and diagnostic performance of a new fast MR sequence EPIMix for neuroradiological evaluation in comparison to computed tomography of brain in pediatric population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 12, 2019

Completed
3 days until next milestone

Study Start

First participant enrolled

February 15, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 20, 2019

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 10, 2020

Completed
2.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2022

Completed
Last Updated

October 17, 2023

Status Verified

October 1, 2023

Enrollment Period

1.1 years

First QC Date

February 12, 2019

Last Update Submit

October 13, 2023

Conditions

Keywords

MRI (magnetic resonance imaging)NeuroradiologyEPIMix (Echo planar imaging mix)Multicontrast EPI (echo planar imaging)Clinical validation

Outcome Measures

Primary Outcomes (2)

  • Tolerance of a new fast MR method in children

    Number of aborted MR

    At 0 hours

  • Diagnostic potential

    Diagnostic accuracy to categorize scan as normal or abnormal on a five point Likert scale (1 - definitely normal, 2 - Probably normal, 3 - Indeterminate, 4 - Probably abnormal, 5 - Definitely abnormal) compared to abnormal/normal brain CT.

    At 0 hours

Secondary Outcomes (8)

  • Lesion classification

    At 0 hours

  • Lesion location determination

    At 0 hours

  • Diagnostic imaging quality

    At 0 hours

  • Lesion description

    At 0 hours

  • Diagnostic confidence

    At 0 hours

  • +3 more secondary outcomes

Interventions

MRIDIAGNOSTIC_TEST

Brain MRI without intravenous contrast

Eligibility Criteria

Age4 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

Child with indication for elective brain CT.

You may qualify if:

  • Age 4-18 years.
  • Patient with suspicion of cerebral pathology.
  • Referral to elective brain CT study.

You may not qualify if:

  • CT planned with sedation
  • known previous cerebral pathology (follow up study)
  • Emergency CT
  • Aborted MR exam

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karolinska University Hospital

Stockholm, Sweden

Location

Related Publications (1)

  • De Luca F, Kits A, Martin Munoz D, Aspelin A, Kvist O, Osterman Y, Diaz Ruiz S, Skare S, Falk Delgado A. Elective one-minute full brain multi-contrast MRI versus brain CT in pediatric patients: a prospective feasibility study. BMC Med Imaging. 2024 Jan 24;24(1):23. doi: 10.1186/s12880-024-01196-6.

MeSH Terms

Conditions

Brain Diseases

Condition Hierarchy (Ancestors)

Central Nervous System DiseasesNervous System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Medical doctor, PhD, Specialist in Neuroradiology

Study Record Dates

First Submitted

February 12, 2019

First Posted

February 20, 2019

Study Start

February 15, 2019

Primary Completion

March 10, 2020

Study Completion

July 30, 2022

Last Updated

October 17, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations